| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.05 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.079 | 0.05 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.05 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.092 | 0.06 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.098 | 0.06 |